Compare ZLAB & CLMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZLAB | CLMT |
|---|---|---|
| Founded | 2013 | 1916 |
| Country | China | United States |
| Employees | N/A | 1630 |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.8B |
| IPO Year | 2017 | 2006 |
| Metric | ZLAB | CLMT |
|---|---|---|
| Price | $17.76 | $20.56 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $57.22 | $20.45 |
| AVG Volume (30 Days) | ★ 806.0K | 532.0K |
| Earning Date | 11-06-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $441,629,000.00 | ★ $4,048,000,000.00 |
| Revenue This Year | $30.20 | $0.16 |
| Revenue Next Year | $34.71 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 24.14 | N/A |
| 52 Week Low | $17.75 | $7.68 |
| 52 Week High | $44.34 | $23.75 |
| Indicator | ZLAB | CLMT |
|---|---|---|
| Relative Strength Index (RSI) | 18.27 | 67.75 |
| Support Level | $19.40 | $19.17 |
| Resistance Level | $20.22 | $19.80 |
| Average True Range (ATR) | 0.52 | 0.53 |
| MACD | 0.09 | 0.13 |
| Stochastic Oscillator | 1.83 | 96.44 |
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.